Atypical glandular cells

Clinical Obstetrics and Gynecology

Volumn 56, Issue 1, 2013, Pages 35-43

  Schorge, John O ^a   Rauh Hain, Jose Alejandro ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL GLANDULAR CELL; CANCER CELL; CANCER INVASION; CANCER MORPHOLOGY; CANCER PREVENTION; CARCINOGENESIS; CLINICAL EVALUATION; COLPOSCOPY; CONFERENCE PAPER; CURETTAGE; CYTOLOGY; CYTOPATHOLOGY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOCOMPROMISED PATIENT; LIQUID BASED CYTOLOGY; NOMENCLATURE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREGNANCY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; UTERINE TUBE CARCINOMA; WART VIRUS;

ADENOCARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; CURETTAGE; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84873412028     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182823849     Document Type: Conference Paper

References (30)

1. Bray F, Carstensen B, Moller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Bio-markers Prev. 2005;14:2191-2199.
2. Gien LT, Beauchemin MC, Thomas G. Adeno-carcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116:140-146.
3. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell car-cinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100:1035-1044.
4. Smith HO, Tiffany MF, Qualls CR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\a 24-year population-based study. Gynecol Oncol. 2000;78:97-105.
5. Lee KR, Flynn CE. Early invasive adenocarcino-ma of the cervix. Cancer. 2000;89:1048-1055.
6. Plaxe SC, Saltzstein SL. Estimation of the dura-tion of the preclinical phase of cervical adenocar-cinoma suggests that there is ample opportunity for screening. Gynecol Oncol. 1999;75:55-61.
7. Zhao C, Florea A, Onisko A. Histologic follow-up results in 662 patients with pap test findings of atypical glandular cells: results from a large aca-demic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114:383-389.
8. Schnatz PF, Guile M, O'Sullivan DM, et al. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol. 2006;107:701-708.
9. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and ap-proved at the National Cancer Institute Work-shop in Bethesda, Maryland, December 12-13, 1988.Hum Pathol. 1990;21:704-708.
10. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the sec-ond National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol. 1993;37:115-124.
11. Solomon D, Davey D, Kurman R, et al. The 2001 bethesda system: terminology for reporting re-sults of cervical cytology. JAMA. 2002;287: 2114-2119.
12. Babkowski RC, Wilbur DC, Rutkowski MA, et al. The effects of endocervical canal topography, tubal metaplasia, and high canal sampling on the cyto-logic presentation of nonneoplastic endocervical cells. Am J Clin Pathol. 1996;105:403-410.
13. Levine L, Lucci JA III, Dinh TV. Atypical glandular cells: new bethesda terminology and management guidelines. Obstet Gynecol Surv. 2003;58:399-406.
14. Lee KR, Darragh TM, Joste NE, et al. Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer prepara-tions. Am J Clin Pathol. 2002;117:96-102.
15. Schorge JO, Hossein SM, Hynan L, et al. Thin-Prep detection ofcervical and endometrial adeno-carcinoma: a retrospective cohort study. Cancer. 2002;96:338-343.
16. Zhou J, Tomashefski JF Jr, Sawady J, et al. The diagnostic value of the thinprep pap test in endome-trial carcinoma: a prospective study with histological follow-up. Diagn Cytopathol. 2012. [Epub ahead of print].
17. Van DT, Haque M, Lucci JA III, et al. Manage-ment of atypical glandular cells of undetermined significance pap smears: a reappraisal. J Low Genit Tract Dis. 2003;7:11-15.
18. Sharpless KE, Schnatz PF, Mandavilli S, et al. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol. 2005;105: 494-500.
19. Sharpless KE, Schnatz PF, Mandavilli S, et al. Lack of adherence to practice guidelines for wom-en with atypical glandular cells on cervical cytol-ogy. Obstet Gynecol. 2005;105:501-506.
20. Diaz-Montes TP, Farinola MA, Zahurak ML, et al. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol. 2007;104:366-371.
21. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guidelines for the management of women with abnormal cervical screening tests. JLow Genit Tract Dis. 2007;11:201-222.
22. Castle PE, Fetterman B, Poitras N, et al. Rela-tionship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. Obstet Gynecol. 2010;115 (pt 1):243-248.
23. Mulhem E, Amin M, Copeland J, et al. Type-specific human papillomavirus DNA detected in atypical glandular cell pap tests. Acta Cytol. 2012;56:155-159.
24. Krane JF, Lee KR, Sun D, et al. Atypical glan-dular cells ofundetermined significance. outcome predictions based on human papillomavirus test-ing. Am J Clin Pathol. 2004;121:87-92.
25. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined signifi-cance (AGUS): cytopathologic features, histopa-thologic results, and human papillomavirus DNA detection. Hum Pathol. 1999;30:816-825.
26. Lacour RA, Garner EI, Molpus KL, et al. Manage-ment of cervical adenocarcinoma in situ during preg-nancy. Am JObstet Gynecol. 2005;192:1449-1451.
27. Slama J, Freitag P, Dundr P, et al. Outcomes of pregnant patients with pap smears classified as atypical glandular cells. Cytopathology. 2012;23: 383-388.
28. Aslan DL, Crapanzano JP, Harshan M, et al. The Bethesda System 2001 recommendation for re-porting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinicalqualifiers. Gynecol Oncol.2007;107:86-93.
29. Casey PM, Gallenberg MM, Kastner TM, et al. Outcomes in women age 40 years and older with cytologically benign endometrial cells. Am J Obstet Gynecol. 2012;207:379.e1-6.
30. Massad LS, Xie X, Darragh TM, et al. Histologic correlates of glandular abnormalities in cer-vical cytology among women with human immunodeficiency virus. Obstet Gynecol. 2009; 114:1063-1068.